Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies - Verena Petzer; Normann Steiner; Olga Angelova-Unterberger; Gabriele Hetzenauer; Kathrin Philipp-Abbrederis; Ella Willenbacher; Clemens Feistritzer; Wolfgang Willenbacher; Jakob Rudzki; Reinhard Stauder; Florian Kocher; Andreas Seeber; et al. (HemaSphere, 2022)